369 related articles for article (PubMed ID: 25850430)
1. Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.
Unmack Larsen I; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A
J Int Neuropsychol Soc; 2015 Mar; 21(3):193-202. PubMed ID: 25850430
[TBL] [Abstract][Full Text] [Related]
2. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
[TBL] [Abstract][Full Text] [Related]
3. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
[TBL] [Abstract][Full Text] [Related]
4. Motor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease.
Hart EP; Dumas EM; Schoonderbeek A; Wolthuis SC; van Zwet EW; Roos RA
Mov Disord; 2014 Mar; 29(3):320-6. PubMed ID: 24500841
[TBL] [Abstract][Full Text] [Related]
5. Do I misconstrue? Sarcasm detection, emotion recognition, and theory of mind in Huntington disease.
Larsen IU; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A
Neuropsychology; 2016 Feb; 30(2):181-9. PubMed ID: 26301773
[TBL] [Abstract][Full Text] [Related]
6. A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease.
Vinther-Jensen T; Larsen IU; Hjermind LE; Budtz-Jørgensen E; Nielsen TT; Nørremølle A; Nielsen JE; Vogel A
Orphanet J Rare Dis; 2014 Jul; 9():114. PubMed ID: 25026978
[TBL] [Abstract][Full Text] [Related]
7. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.
Lemiere J; Decruyenaere M; Evers-Kiebooms G; Vandenbussche E; Dom R
J Neurol; 2004 Aug; 251(8):935-42. PubMed ID: 15316797
[TBL] [Abstract][Full Text] [Related]
8. Visual Object Perception in Premanifest and Early Manifest Huntington's Disease.
Coppen EM; Jacobs M; van der Zwaan KF; Middelkoop HAM; Roos RAC
Arch Clin Neuropsychol; 2019 Nov; 34(8):1320-1328. PubMed ID: 30796801
[TBL] [Abstract][Full Text] [Related]
9. Theory of mind can be impaired prior to motor onset in Huntington's disease.
Eddy CM; Rickards HE
Neuropsychology; 2015 Sep; 29(5):792-8. PubMed ID: 25664466
[TBL] [Abstract][Full Text] [Related]
10. Task-switching abilities in pre-manifest Huntington's disease subjects.
Migliore S; D'Aurizio G; Curcio G; Squitieri F
Parkinsonism Relat Disord; 2019 Mar; 60():111-117. PubMed ID: 30201420
[TBL] [Abstract][Full Text] [Related]
11. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene.
Verny C; Allain P; Prudean A; Malinge MC; Gohier B; Scherer C; Bonneau D; Dubas F; Le Gall D
Eur J Neurol; 2007 Dec; 14(12):1344-50. PubMed ID: 17941857
[TBL] [Abstract][Full Text] [Related]
12. Early cognitive deficits in Swedish gene carriers of Huntington's disease.
Robins Wahlin TB; Lundin A; Dear K
Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528
[TBL] [Abstract][Full Text] [Related]
13. Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease.
Herben-Dekker M; van Oostrom JC; Roos RA; Jurgens CK; Witjes-Ané MN; Kremer HP; Leenders KL; Spikman JM
J Neurol; 2014 Jul; 261(7):1387-97. PubMed ID: 24781835
[TBL] [Abstract][Full Text] [Related]
14. Dissociation between decision-making under risk and decision-making under ambiguity in premanifest and manifest Huntington's disease.
Adjeroud N; Besnard J; Verny C; Prundean A; Scherer C; Gohier B; Bonneau D; Massioui NE; Allain P
Neuropsychologia; 2017 Aug; 103():87-95. PubMed ID: 28712946
[TBL] [Abstract][Full Text] [Related]
15. Prefrontal executive function associated coupling relates to Huntington's disease stage.
Unschuld PG; Liu X; Shanahan M; Margolis RL; Bassett SS; Brandt J; Schretlen DJ; Redgrave GW; Hua J; Hock C; Reading SA; van Zijl PC; Pekar JJ; Ross CA
Cortex; 2013; 49(10):2661-73. PubMed ID: 23906595
[TBL] [Abstract][Full Text] [Related]
16. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
17. The Visual Spatial Learning Test: differential impairment during the premanifest and manifest stages of Huntington's disease.
Pirogovsky E; Nicoll DR; Challener DM; Breen E; Gluhm S; Corey-Bloom J; Gilbert PE
J Neuropsychol; 2015 Mar; 9(1):77-86. PubMed ID: 24330469
[TBL] [Abstract][Full Text] [Related]
18. Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease.
Dumas EM; Say MJ; Jones R; Labuschagne I; O'Regan AM; Hart EP; van den Bogaard SJ; Queller S; Justo D; Coleman A; Dar Santos RC; Dürr A; Leavitt BR; Tabrizi SJ; Roos RA; Stout JC
J Huntingtons Dis; 2012; 1(1):97-106. PubMed ID: 25063192
[TBL] [Abstract][Full Text] [Related]
19. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
[TBL] [Abstract][Full Text] [Related]
20. Executive functions in premanifest Huntington's disease.
You SC; Geschwind MD; Sha SJ; Apple A; Satris G; Wood KA; Johnson ET; Gooblar J; Feuerstein JS; Finkbeiner S; Kang GA; Miller BL; Hess CP; Kramer JH; Possin KL
Mov Disord; 2014 Mar; 29(3):405-9. PubMed ID: 24375511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
